Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.

Husby S, Favero F, Nielsen C, Sørensen BS, Bæch J, Grell K, Hansen JW, Rodriguez-Gonzalez FG, Haastrup EK, Fischer-Nielsen A, Andersen P, Arboe B, Sækmose SG, Hansen PB, Christiansen I, Clasen-Linde E, Meldgaard L, Ebbesen LH, Segel EK, Josefsson P, Thorsgaard M, El-Galaly TC, Brown P, Weischenfeldt J, Larsen TS, Grønbæk K.

Leukemia. 2020 Mar 20. doi: 10.1038/s41375-020-0795-z. [Epub ahead of print]

PMID:
32203146
2.

Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms.

Pedersen RK, Andersen M, Knudsen TA, Sajid Z, Gudmand-Hoeyer J, Dam MJB, Skov V, Kjaer L, Ellervik C, Larsen TS, Hansen D, Pallisgaard N, Hasselbalch HC, Ottesen JT.

Cancer Med. 2020 Mar;9(6):2039-2051. doi: 10.1002/cam4.2741. Epub 2020 Jan 28.

3.

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.

Sørensen AL, Mikkelsen SU, Knudsen TA, Bjørn ME, Andersen CL, Bjerrum OW, Brochmann N, Patel DA, Gjerdrum LMR, El Fassi D, Kruse TA, Larsen TS, Mourits-Andersen HT, Nielsen CH, Ellervik C, Pallisgaard N, Thomassen M, Kjær L, Skov V, Hasselbalch HC.

Haematologica. 2019 Dec 26. pii: haematol.2019.235648. doi: 10.3324/haematol.2019.235648. [Epub ahead of print]

4.

Altered mitochondrial metabolism in the insulin-resistant heart.

Makrecka-Kuka M, Liepinsh E, Murray AJ, Lemieux H, Dambrova M, Tepp K, Puurand M, Käämbre T, Han WH, de Goede P, O'Brien KA, Turan B, Tuncay E, Olgar Y, Rolo AP, Palmeira CM, Boardman NT, Wüst RCI, Larsen TS.

Acta Physiol (Oxf). 2020 Mar;228(3):e13430. doi: 10.1111/apha.13430. Epub 2019 Dec 30. Review.

PMID:
31840389
5.

Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy.

Clausen MR, Maurer MJ, Ulrichsen SP, Larsen TS, Himmelstrup B, Rønnov-Jessen D, Link BK, Feldman AL, Slager SL, Nowakowski GS, Thompson CA, Pedersen PT, Madsen J, Pedersen RS, Gørløv JS, Cerhan JR, Nørgaard M, D'Amore F.

Clin Epidemiol. 2019 Nov 14;11:987-996. doi: 10.2147/CLEP.S219595. eCollection 2019.

6.

Perioperative Infusion of Glucagon-Like Peptide-1 Prevents Insulin Resistance After Surgical Trauma in Female Pigs.

Hagve M, Gjessing PF, Hole MJ, Jansen KM, Fuskevåg OM, Mollnes TE, Larsen TS, Irtun Ø.

Endocrinology. 2019 Dec 1;160(12):2892-2902. doi: 10.1210/en.2019-00374.

PMID:
31589305
7.

Dietary Calanus oil recovers metabolic flexibility and rescues postischemic cardiac function in obese female mice.

Jansen KM, Moreno S, Garcia-Roves PM, Larsen TS.

Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H290-H299. doi: 10.1152/ajpheart.00191.2019. Epub 2019 May 24.

PMID:
31125256
8.

Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma.

Biccler JL, Savage KJ, Brown PDN, Jørgensen J, Larsen TS, Poulsen CB, Stoltenberg D, Sehn LH, Scott DW, Gerrie AS, Jakobsen LH, Bøgsted M, El-Galaly TC, Villa D.

Leuk Lymphoma. 2019 Oct;60(10):2516-2523. doi: 10.1080/10428194.2019.1594219. Epub 2019 Apr 3.

PMID:
30943052
9.

Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.

Clausen MR, Ulrichsen SP, Larsen TS, Poulsen CB, Tojaga S, Pedersen PT, Madsen J, Pedersen RS, Josefsson PL, Gørløv JS, Nørgaard M, d'Amore F.

Leuk Lymphoma. 2019 Aug;60(8):1950-1957. doi: 10.1080/10428194.2018.1554863. Epub 2019 Jan 22.

PMID:
30668181
10.

Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review.

Jelicic J, Larsen TS, Maksimovic M, Trajkovic G.

Crit Rev Oncol Hematol. 2019 Jan;133:1-16. doi: 10.1016/j.critrevonc.2018.10.006. Epub 2018 Nov 1.

PMID:
30661646
11.

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.

Czech J, Cordua S, Weinbergerova B, Baumeister J, Crepcia A, Han L, Maié T, Costa IG, Denecke B, Maurer A, Schubert C, Feldberg K, Gezer D, Brümmendorf TH, Müller-Newen G, Mayer J, Racil Z, Kubesova B, Knudsen T, Sørensen AL, Holmström M, Kjær L, Skov V, Larsen TS, Hasselbalch HC, Chatain N, Koschmieder S.

Leukemia. 2019 Apr;33(4):995-1010. doi: 10.1038/s41375-018-0295-6. Epub 2018 Nov 23.

PMID:
30470838
12.

Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Nielsen HM, Andersen CL, Westman M, Kristensen LS, Asmar F, Kruse TA, Thomassen M, Larsen TS, Skov V, Hansen LL, Bjerrum OW, Hasselbalch HC, Punj V, Grønbæk K.

Sci Rep. 2018 Nov 20;8(1):17311. doi: 10.1038/s41598-018-35596-w.

13.

Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.

Brabrand M, Hansen KN, Laursen CB, Larsen TS, Vestergaard H, Abildgaard N.

Eur J Haematol. 2019 Mar;102(3):227-234. doi: 10.1111/ejh.13197. Epub 2019 Jan 10.

PMID:
30450659
14.

Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment.

Daugaard I, Hussmann D, Kristensen L, Kristensen T, Kjeldsen TE, Nyvold CG, Larsen TS, Møller MB, Hansen LL, Wojdacz TK.

Epigenomics. 2018 Sep;10(9):1155-1166. doi: 10.2217/epi-2018-0020. Epub 2018 Sep 5.

PMID:
30182737
15.

Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study.

Juul MB, Jensen PH, Engberg H, Wehberg S, Dessau-Arp A, Haziri D, Kristensen HB, Baech J, Schurmann L, Clausen MR, Valentin R, Knudsen LM, Munksgaard L, El-Galaly TC, Frederiksen H, Larsen TS.

Eur J Cancer. 2018 Aug;99:86-96. doi: 10.1016/j.ejca.2018.05.006. Epub 2018 Jun 20.

PMID:
29935491
16.

Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis.

Mikkelsen SU, Kjaer L, Bjørn ME, Knudsen TA, Sørensen AL, Andersen CBL, Bjerrum OW, Brochmann N, Fassi DE, Kruse TA, Larsen TS, Mourits-Andersen HT, Nielsen CH, Pallisgaard N, Thomassen M, Skov V, Hasselbalch HC.

Cancer Med. 2018 Aug;7(8):3571-3581. doi: 10.1002/cam4.1619. Epub 2018 Jun 22.

17.

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

El-Galaly TC, Cheah CY, Bendtsen MD, Nowakowski GS, Kansara R, Savage KJ, Connors JM, Sehn LH, Goldschmidt N, Shaulov A, Farooq U, Link BK, Ferreri AJM, Calimeri T, Cecchetti C, Dann EJ, Thompson CA, Inbar T, Maurer MJ, Gade IL, Juul MB, Hansen JW, Holmberg S, Larsen TS, Cordua S, Mikhaeel NG, Hutchings M, Seymour JF, Clausen MR, Smith D, Opat S, Gilbertson M, Thanarajasingam G, Villa D.

Eur J Cancer. 2018 Apr;93:57-68. doi: 10.1016/j.ejca.2018.01.073. Epub 2018 Feb 21.

18.

Estimation of the transmission dynamics of African swine fever virus within a swine house.

Nielsen JP, Larsen TS, Halasa T, Christiansen LE.

Epidemiol Infect. 2017 Oct;145(13):2787-2796. doi: 10.1017/S0950268817001613. Epub 2017 Aug 3.

PMID:
28768556
19.

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Nielsen HM, Andersen CL, Westman M, Kristensen LS, Asmar F, Kruse TA, Thomassen M, Larsen TS, Skov V, Hansen LL, Bjerrum OW, Hasselbalch HC, Punj V, Grønbæk K.

Sci Rep. 2017 Jul 28;7(1):6774. doi: 10.1038/s41598-017-07057-3. Erratum in: Sci Rep. 2018 Nov 20;8(1):17311.

20.

Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma.

Bech RS, Nielsen KL, Larsen TS, Bentzen HH, Lynggaard LS, Do TH, Braendstrup P, Brady J, Mikhaeel NG, Dybkaer K, Johnsen HE, Jensen P, Bøgsted M, El-Galaly TC.

Br J Haematol. 2018 Jul;182(2):297-301. doi: 10.1111/bjh.14775. Epub 2017 May 23. No abstract available.

PMID:
28542714
21.

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.

El-Galaly TC, Villa D, Michaelsen TY, Hutchings M, Mikhaeel NG, Savage KJ, Sehn LH, Barrington S, Hansen JW, Smith D, Rady K, Mylam KJ, Larsen TS, Holmberg S, Juul MB, Cordua S, Clausen MR, Jensen KB, Johnsen HE, Seymour JF, Connors JM, de Nully Brown P, Bøgsted M, Cheah CY.

Eur J Cancer. 2017 Apr;75:195-203. doi: 10.1016/j.ejca.2016.12.029. Epub 2017 Feb 23.

PMID:
28237865
22.

Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study.

Jakobsen LH, Bøgsted M, Brown PN, Arboe B, Jørgensen J, Larsen TS, Juul MB, Schurmann L, Højberg L, Bergmann OJ, Lassen T, Josefsson PL, Jensen P, Johnsen HE, El-Galaly TC.

J Clin Oncol. 2017 Mar;35(7):778-784. doi: 10.1200/JCO.2016.70.0765. Epub 2017 Jan 17.

PMID:
28095160
23.

Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment.

Kjær L, Cordua S, Holmström MO, Thomassen M, Kruse TA, Pallisgaard N, Larsen TS, de Stricker K, Skov V, Hasselbalch HC.

PLoS One. 2016 Oct 20;11(10):e0165336. doi: 10.1371/journal.pone.0165336. eCollection 2016.

24.

Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.

El-Galaly TC, Cheah CY, Hutchings M, Mikhaeel NG, Savage KJ, Sehn LH, Barrington S, Hansen JW, Poulsen MØ, Smith D, Rady K, Mylam KJ, Larsen TS, Holmberg S, Juul MB, Cordua S, Clausen MR, Jensen KB, Bøgsted M, Johnsen HE, Seymour JF, Connors JM, Brown PD, Villa D.

Br J Haematol. 2016 Dec;175(5):876-883. doi: 10.1111/bjh.14325. Epub 2016 Sep 29.

PMID:
27681999
25.

Wax Ester Rich Oil From The Marine Crustacean, Calanus finmarchicus, is a Bioavailable Source of EPA and DHA for Human Consumption.

Cook CM, Larsen TS, Derrig LD, Kelly KM, Tande KS.

Lipids. 2016 Oct;51(10):1137-1144. doi: 10.1007/s11745-016-4189-y. Epub 2016 Sep 7.

PMID:
27604086
26.

Dietary Calanus oil antagonizes angiotensin II-induced hypertension and tissue wasting in diet-induced obese mice.

Salma W, Franekova V, Lund T, Höper A, Ludvigsen S, Lund J, Aasum E, Ytrehus K, Belke DD, Larsen TS.

Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:13-21. doi: 10.1016/j.plefa.2016.03.006. Epub 2016 Mar 24.

PMID:
27154360
27.

Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.

Christlieb SB, Strandholdt CN, Olsen BB, Mylam KJ, Larsen TS, Nielsen AL, Rohde M, Gerke O, Olsen KE, Møller MB, Kristensen BW, Abildgaard N, Alavi A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1824-36. doi: 10.1007/s00259-016-3385-6. Epub 2016 Apr 22.

PMID:
27102266
28.

Trends in hematological cancer in the elderly in Denmark, 1980-2012.

Ocias LF, Larsen TS, Vestergaard H, Friis LS, Abildgaard N, Frederiksen H; Academy of Geriatric Cancer Research (AgeCare).

Acta Oncol. 2016;55 Suppl 1:98-107. doi: 10.3109/0284186X.2015.1115124. Epub 2016 Jan 19.

PMID:
26783877
29.

Response to Letter Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity".

Bakkehaug JP, Kildal AB, Engstad ET, Boardman N, Næsheim T, Rønning L, Aasum E, Larsen TS, Myrmel T, How OJ.

Circ Heart Fail. 2015 Nov;8(6):1142. doi: 10.1161/CIRCHEARTFAILURE.115.002548. No abstract available.

PMID:
26738203
30.

Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study.

Frederiksen H, Farkas DK, Christiansen CF, Larsen TS, Hasselbalch HC, Stentoft J, Sørensen HT.

Lancet Haematol. 2015 Jul;2(7):e289-96. doi: 10.1016/S2352-3026(15)00092-7. Epub 2015 Jun 11.

PMID:
26688384
31.

Primary thymic extranodal marginal zone B cell lymphoma as an incidental finding in a Caucasian woman.

Petersen JK, Larsen TS, Møller MB, Stahlberg C.

BMJ Case Rep. 2015 Sep 3;2015. pii: bcr2015211469. doi: 10.1136/bcr-2015-211469.

32.

Robust fluidic connections to freestanding microfluidic hydrogels.

Faley SL, Baer BB, Larsen TS, Bellan LM.

Biomicrofluidics. 2015 May 20;9(3):036501. doi: 10.1063/1.4921453. eCollection 2015 May.

33.

Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity.

Bakkehaug JP, Kildal AB, Engstad ET, Boardman N, Næsheim T, Rønning L, Aasum E, Larsen TS, Myrmel T, How OJ.

Circ Heart Fail. 2015 Jul;8(4):766-75. doi: 10.1161/CIRCHEARTFAILURE.114.002152. Epub 2015 May 29.

PMID:
26025342
34.

[New disease markers within the chronic myeloproliferative neoplasms].

Holmström MO, Ocias LF, Kallenbach K, Kjær L, Kristensen TK, Pallisgaard N, Petersen BL, Skov V, de Stricker K, Larsen TS, Hasselbalch HC.

Ugeskr Laeger. 2015 May 4;177(19). pii: V12140653. Review. Danish.

PMID:
25967091
35.

[Status and perspectives on chronic myeloproliferative neoplasm treatment].

Ocias LF, Holmström MO, Riley CH, Andersen CL, Rønnov-Jessen D, Starklint J, Frederiksen M, Steffensen MS, Bjerrum OW, Farmer S, Mourits-Andersen T, Hasselbalch HC, Larsen TS.

Ugeskr Laeger. 2015 May 4;177(19). pii: V12140652. Review. Danish.

PMID:
25967090
36.

Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera.

Utke Rank C, Weis Bjerrum O, Larsen TS, Kjær L, de Stricker K, Riley CH, Hasselbalch HC.

Leuk Lymphoma. 2016 Feb;57(2):348-354. doi: 10.3109/10428194.2015.1049171. Epub 2015 Jun 18.

PMID:
25956046
37.

Skeletal muscle mitochondria exhibit decreased pyruvate oxidation capacity and increased ROS emission during surgery-induced acute insulin resistance.

Hagve M, Gjessing PF, Fuskevåg OM, Larsen TS, Irtun Ø.

Am J Physiol Endocrinol Metab. 2015 Apr 15;308(8):E613-20. doi: 10.1152/ajpendo.00459.2014. Epub 2015 Feb 10.

38.

Exercise training promotes cardioprotection through oxygen-sparing action in high fat-fed mice.

Lund J, Hafstad AD, Boardman NT, Rossvoll L, Rolim NP, Ahmed MS, Florholmen G, Attramadal H, Wisløff U, Larsen TS, Aasum E.

Am J Physiol Heart Circ Physiol. 2015 Apr 15;308(8):H823-9. doi: 10.1152/ajpheart.00734.2014. Epub 2015 Jan 30.

39.

Marine omega-3 fatty acids prevent myocardial insulin resistance and metabolic remodeling as induced experimentally by high insulin exposure.

Franekova V, Angin Y, Hoebers NT, Coumans WA, Simons PJ, Glatz JF, Luiken JJ, Larsen TS.

Am J Physiol Cell Physiol. 2015 Feb 15;308(4):C297-307. doi: 10.1152/ajpcell.00073.2014. Epub 2014 Dec 3.

40.

Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression.

Hasselbalch HC, Thomassen M, Riley CH, Kjær L, Larsen TS, Jensen MK, Bjerrum OW, Kruse TA, Skov V.

PLoS One. 2014 Nov 14;9(11):e112786. doi: 10.1371/journal.pone.0112786. eCollection 2014. Erratum in: PLoS One. 2015;10(2):e0118049.

41.

The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations.

Stenberg TA, Kildal AB, Sanden E, How OJ, Hagve M, Ytrehus K, Larsen TS, Myrmel T.

PLoS One. 2014 Sep 4;9(9):e105213. doi: 10.1371/journal.pone.0105213. eCollection 2014.

42.

Primary CNS lymphoma in a patient treated with azathioprine.

Glesner MK, Ocias LF, Larsen TS, Pedersen C.

BMJ Case Rep. 2014 Sep 1;2014. pii: bcr2014205108. doi: 10.1136/bcr-2014-205108.

43.

Propargylamine-isothiocyanate reaction: efficient conjugation chemistry in aqueous media.

Viart HM, Larsen TS, Tassone C, Andresen TL, Clausen MH.

Chem Commun (Camb). 2014 Jul 25;50(58):7800-2. doi: 10.1039/c4cc00863d.

PMID:
24903342
44.

Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.

Höper AC, Salma W, Sollie SJ, Hafstad AD, Lund J, Khalid AM, Raa J, Aasum E, Larsen TS.

J Nutr. 2014 Feb;144(2):164-9. doi: 10.3945/jn.113.182501. Epub 2013 Nov 27.

PMID:
24285691
45.

Oil from the marine zooplankton Calanus finmarchicus improves the cardiometabolic phenotype of diet-induced obese mice.

Höper AC, Salma W, Khalid AM, Hafstad AD, Sollie SJ, Raa J, Larsen TS, Aasum E.

Br J Nutr. 2013 Dec;110(12):2186-93. doi: 10.1017/S0007114513001839. Epub 2013 Jun 17.

PMID:
23768435
46.

High- and moderate-intensity training normalizes ventricular function and mechanoenergetics in mice with diet-induced obesity.

Hafstad AD, Lund J, Hadler-Olsen E, Höper AC, Larsen TS, Aasum E.

Diabetes. 2013 Jul;62(7):2287-94. doi: 10.2337/db12-1580. Epub 2013 Mar 14.

47.

Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis.

Skov V, Riley CH, Thomassen M, Larsen TS, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC.

Leuk Lymphoma. 2013 Oct;54(10):2269-73. doi: 10.3109/10428194.2013.764417. Epub 2013 May 15.

PMID:
23302045
48.

Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillance.

Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC.

Leuk Res. 2012 Nov;36(11):1387-92. doi: 10.1016/j.leukres.2012.07.009. Epub 2012 Aug 9.

PMID:
22877729
49.

Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis.

Skov V, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC, Larsen TS.

Exp Hematol. 2012 Sep;40(9):771-780.e19. doi: 10.1016/j.exphem.2012.05.011. Epub 2012 Jun 1.

PMID:
22659388
50.

Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.

von Lueder TG, Gravning J, How OJ, Vinge LE, Ahmed MS, Krobert KA, Levy FO, Larsen TS, Smiseth OA, Aasum E, Attramadal H.

Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H66-74. doi: 10.1152/ajpheart.00724.2011. Epub 2012 Apr 27.

Supplemental Content

Loading ...
Support Center